✦ LIBER ✦

Paclitaxel, Ifosfamide and Cisplatin (TIP) chemotherapy for recurrent or advanced squamous cell cervical cancer (SCCC)

✍ Scribed by G. Zanetta; F. Fei; G. Parma; M. Balestrino; C. Mangioni

Book ID: 117667864
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 149 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81325-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with mitomycin c, ifosfamid

Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer

✍ K. SERKIES; J. JASSEM; R. DZIADZIUSZKO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Combination chemotherapy with 254-S, ifo

Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer

✍ Koji Hirabayashi; Etsuko Okada 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

A phase II study of biweekly paclitaxel

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

✍ Jing Huang, Yi Zhou, Hongtu Zhang, Tao Qu, Yousheng Mao, Hongxia Zhu, Lanping Qu 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 374 KB

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

PCN14 AN INDIRECT COMPARISON OF THE EFFI

PCN14 AN INDIRECT COMPARISON OF THE EFFICACY OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) OR BEVACIZUMAB PLUS CARBOPLATIN AND PACLITAXEL (BCP) VERSUS CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

✍ S Walzer; J de Castro Carpeño; A Vergnenegre; C Chouaid; D Heigener; HG Bischoff 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB